Jernström H - Search Results

1

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Jernström H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA. Jernström H, et al. J Natl Cancer Inst. 2004 Jul 21;96(14):1094-8. doi: 10.1093/jnci/djh211. J Natl Cancer Inst. 2004. PMID: 15265971

2

Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habits.

Jernström H, Knutsson M, Taskila P, Olsson H. Jernström H, et al. Contraception. 1992 Dec;46(6):543-8. doi: 10.1016/0010-7824(92)90119-e. Contraception. 1992. PMID: 1493714

3

Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives.

Jernström H, Olsson H. Jernström H, et al. Gynecol Obstet Invest. 1994;38(4):261-5. doi: 10.1159/000292493. Gynecol Obstet Invest. 1994. PMID: 7851812

4

Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use.

Jernstrom H, Knutsson M, Olsson H. Jernstrom H, et al. Contraception. 1995 Jul;52(1):51-6. doi: 10.1016/0010-7824(95)00124-s. Contraception. 1995. PMID: 8521715

5

Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors.

Olsson H, Jernström H, Alm P, Kreipe H, Ingvar C, Jönsson PE, Rydén S. Olsson H, et al. Among authors: jernstrom h. Breast Cancer Res Treat. 1996;40(2):187-96. doi: 10.1007/BF01806214. Breast Cancer Res Treat. 1996. PMID: 8879685

6

Breast size in relation to endogenous hormone levels, body constitution, and oral contraceptive use in healthy nulligravid women aged 19-25 years.

Jernström H, Olsson H. Jernström H, et al. Am J Epidemiol. 1997 Apr 1;145(7):571-80. doi: 10.1093/oxfordjournals.aje.a009153. Am J Epidemiol. 1997. PMID: 9098173

7

Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patients.

Jernström HC, Olsson H, Borg A. Jernström HC, et al. Eur J Cancer Prev. 1997 Aug;6(4):330-40. doi: 10.1097/00008469-199708000-00004. Eur J Cancer Prev. 1997. PMID: 9370095 Clinical Trial.

8

BRCA1-positive patients are small for gestational age compared with their unaffected relatives.

Jernström H, Johannsson O, Borg A, Ivarsson H, Olsson H. Jernström H, et al. Eur J Cancer. 1998 Feb;34(3):368-71. doi: 10.1016/s0959-8049(97)10088-0. Eur J Cancer. 1998. PMID: 9640224

9

Insulin-like growth factor-1 in relation to adult weight and birth weight in healthy nulliparous women.

Jernström H, Olsson H. Jernström H, et al. Int J Gynaecol Obstet. 1998 Jul;62(1):11-8. doi: 10.1016/s0020-7292(98)00060-5. Int J Gynaecol Obstet. 1998. PMID: 9722119

10

Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients.

Jernström H, Frenander J, Fernö M, Olsson H. Jernström H, et al. Br J Cancer. 1999 Jul;80(9):1453-8. doi: 10.1038/sj.bjc.6690543. Br J Cancer. 1999. PMID: 10424750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters